All In Biotech

Drug Trial Radar · NCT04343287

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model

Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 220 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

220

Actual

Start

Jan 15, 2020

Primary completion

Jun 23, 2020

Study completion Jun 23, 2020

Sponsor

Lead sponsor
BRIM Biotechnology Inc.Industry
Sponsor type
Industry
First posted
Apr 13, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Conditions

  • Dry Eye Syndrome

Interventions

  • BRM421Drug

    The active control with BRM421 solution

  • PlaceboDrug

    The vehicle solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular Sign: Change From Baseline in Total Corneal Staining Score to Day 14Time frame: change from baseline to 2 weeks
  2. Ocular Symptom: Change From Baseline in Patient-Reported Ocular Dryness Score to Day 14, Using Ora Calibra® Ocular Discomfort & 4-Symptom QuestionnaireTime frame: change from baseline to 2 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Eye Research Foundation

    Newport Beach, California

  • Midwest Cornea Associates, LLC

    Indianapolis, Indiana

  • Andover Eye Associates

    Andover, Massachusetts

  • Total Eye Care

    Memphis, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.